Showing results (751-760 of 991) with videos related to
Sort By:
Pageof 100
Therapeutic Advances in Respiratory Disease|March 11, 2022
A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosisEdward F Nash, Jocelyn Choyce, Victoria Carrolan, et al.Therapeutic Advances in Respiratory Disease|July 5, 2019
Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) versus low PEEP on patients with moderate-severe acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trialsXi Zheng, Yijia Jiang, Huimiao Jia, et al.Therapeutic Advances in Respiratory Disease|April 28, 2019
The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapySherstin T Lommatzsch, Jennifer L Taylor-CousarTherapeutic Advances in Respiratory Disease|January 3, 2026
Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosisSydney Blankenship, Benjamin V Flueckiger, Godsgift Caleb, et al.Therapeutic Advances in Respiratory Disease|April 24, 2015
Best practice in the treatment of advanced squamous cell lung cancerYvonne L E Ang, Hon-Lyn Tan, Ross A SooTherapeutic Advances in Respiratory Disease|April 24, 2015
When a respiratory pathogen turns to the skin: cutaneous tuberculosis in a lung transplant patientTorsten Voigtländer, Markus Cornberg, Jens Gottlieb, et al.Therapeutic Advances in Respiratory Disease|April 10, 2020
Lymphocyte senescence in COPD is associated with decreased sirtuin 1 expression in steroid resistant pro-inflammatory lymphocytesGreg Hodge, Hai B Tran, Paul N Reynolds, et al.Therapeutic Advances in Respiratory Disease|November 17, 2010
Changing epidemiology and clinical issues arising in an ageing cystic fibrosis populationMichael D Parkins, Vicky M Parkins, Jackie C Rendall, et al.Therapeutic Advances in Respiratory Disease|October 9, 2010
Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2 models of infectionMario Cazzola, Thomas A Tompkins, Maria G MateraTherapeutic Advances in Respiratory Disease|April 15, 2010
Management of multidrug-resistant tuberculosis: an updateIgnacio Monedero, José A CamineroPageof 100